{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:35:12Z","timestamp":1777455312897,"version":"3.51.4"},"reference-count":35,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Clin Med\ufffdInsights\ufffdBlood\ufffdDisord"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:p>The spleen is among the most common extranodal sites for Hodgkin and non-Hodgkin lymphomas (NHLs); however, among lymphomas arising from the spleen, primary splenic lymphomas (PSLs) are rare. The group of PSLs includes primary splenic diffuse large B-cell lymphoma (PS-DLBCL), splenic red pulp small B-cell lymphoma, splenic marginal zone lymphoma (SMZL), and a splenic hairy cell leukemia variant. Delineating between the PSL variants can be challenging, especially as fine-needle aspirate and core needle biopsy of the spleen are not routinely offered at most medical centers. Herein, we describe the clinical course of 2 representative patients who presented with non-specific gastrointestinal symptoms, the first who was diagnosed with PS-DLBCL and the second who was diagnosed with SMZL. We review and contrast the clinical presentations, imaging techniques, and laboratory findings of these discrete lymphoma variants and offer strategies on how to delineate between these varied splenic processes. We also examine the use of splenectomy and splenic needle biopsy as diagnostics and, in the case of splenectomy, a therapeutic tool. Finally, we also briefly review treatment options for these varied lymphoma sub-types while acknowledging that randomized trials to guide best practices for PSLs are lacking.<\/jats:p>","DOI":"10.1177\/1179545x20926188","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T07:24:16Z","timestamp":1591773856000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["Rare Causes of Isolated and Progressive Splenic Lesions: Challenges in Differential Diagnosis, Evaluation, and Treatment of Primary Splenic Lymphomas"],"prefix":"10.1177","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4919-8890","authenticated-orcid":false,"given":"Ryan B","family":"Sinit","sequence":"first","affiliation":[{"name":"Floyd & Delores Jones Cancer Institute, Virginia Mason Medical Center, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell K","family":"Dorer","sequence":"additional","affiliation":[{"name":"Department of Pathology, Virginia Mason Medical Center, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Paul","family":"Flores","sequence":"additional","affiliation":[{"name":"Floyd & Delores Jones Cancer Institute, Virginia Mason Medical Center, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6752-3530","authenticated-orcid":false,"given":"David M","family":"Aboulafia","sequence":"additional","affiliation":[{"name":"Floyd & Delores Jones Cancer Institute, Virginia Mason Medical Center, Seattle, WA, USA"},{"name":"Division of Hematology, School of Medicine, University of Washington, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,6,10]]},"reference":[{"key":"bibr1-1179545X20926188","first-page":"88","volume":"169","author":"O\u2019Reilly RA","year":"1998","journal-title":"West J Med"},{"key":"bibr2-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.1102\/1470-7330.2010.0026"},{"key":"bibr3-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-038257"},{"key":"bibr4-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.1148\/rg.301095088"},{"key":"bibr5-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/31542964"},{"key":"bibr6-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v4.i12.385"},{"key":"bibr7-1179545X20926188","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow SH","year":"2017","edition":"4"},{"key":"bibr8-1179545X20926188","first-page":"947","volume":"120","author":"Dasgupta T","year":"1965","journal-title":"Surg Gynecol Obstet"},{"key":"bibr9-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19881001)62:7<1433::AID-CNCR2820620731>3.0.CO;2-V"},{"key":"bibr10-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-09-271437"},{"key":"bibr11-1179545X20926188","first-page":"e3026","volume":"10","author":"Khalid S","year":"2018","journal-title":"Cureus"},{"key":"bibr12-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.1016\/j.kjms.2012.08.025"},{"key":"bibr13-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29487"},{"key":"bibr14-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.28"},{"key":"bibr15-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2008.10.001"},{"key":"bibr16-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19841201)54:11<2460::AID-CNCR2820541125>3.0.CO;2-K"},{"key":"bibr17-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2012.02844.x"},{"key":"bibr18-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2005.06.005"},{"key":"bibr19-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2008.01081.x"},{"key":"bibr20-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-10-200605160-00004"},{"key":"bibr21-1179545X20926188","first-page":"6839","volume":"37","author":"Byrd KP","year":"2017","journal-title":"Anticancer Res"},{"key":"bibr22-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2016.12.759"},{"key":"bibr23-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.15.15125"},{"key":"bibr24-1179545X20926188","volume-title":"Rituxan (Rituximab) BL 1037095 Approval Letter","author":"U.S. Food and Drug Administration","year":"2006"},{"key":"bibr25-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(196604)19:4<461::AID-CNCR2820190402>3.0.CO;2-X"},{"key":"bibr26-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930101)71:1<207::AID-CNCR2820710132>3.0.CO;2-0"},{"key":"bibr27-1179545X20926188","volume-title":"B-Cell Lymphomas (Version 2)","author":"National Comprehensive Cancer Network","year":"2019"},{"key":"bibr28-1179545X20926188","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S2055-6640(20)30324-1","volume":"3","author":"Hill A","year":"2017","journal-title":"J Virus Erad"},{"key":"bibr29-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27950"},{"key":"bibr30-1179545X20926188","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/annonc\/mdr207","volume":"22","author":"Arcaini L","year":"2011","journal-title":"Ann Oncol"},{"key":"bibr31-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.092460"},{"key":"bibr32-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19950115)75:2<577::AID-CNCR2820750222>3.0.CO;2-K"},{"key":"bibr33-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(96)00196-1"},{"key":"bibr34-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.9738\/CC63.1"},{"key":"bibr35-1179545X20926188","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-12-619122"}],"container-title":["Clinical Medicine Insights: Blood Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1179545X20926188","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1179545X20926188","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1179545X20926188","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:58:48Z","timestamp":1777381128000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1179545X20926188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":35,"alternative-id":["10.1177\/1179545X20926188"],"URL":"https:\/\/doi.org\/10.1177\/1179545x20926188","relation":{},"ISSN":["1179-545X","1179-545X"],"issn-type":[{"value":"1179-545X","type":"print"},{"value":"1179-545X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]},"article-number":"1179545X20926188"}}